Analyst Michael Schmidt works at GUGGENHEIM and is focused on the Healthcare sector with 326 price targets and ratings documented since 2013 spanning on 29 stocks. Previously, Michael Schmidt worked at LEERINK. Analyst's average stock valuation to be materialised ratio is 60.57% with an average time for price targets to be met of 203.75 days.
Most recent stock forecast was given on BGNE, BeiGene, Ltd at 20-Jan-2023.
Michael Schmidt best performing recommendations are on IONS (IONIS PHARMACEUTICALS, INC).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS, INC) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
9 months 1 days ago
0/5 (0%)
$9.4 (88.90%)
Hold
1 years 3 months 3 days ago
10/11 (90.91%)
$-0.17 (0.33%)
77
Sell
5
$4.88 (4066.67%)
4
1 years 10 months 18 days ago
4/6 (66.67%)
$7.88 (-2.48%)
175
Sell
3
$2.88 (2400.00%)
4
2 years 3 months ago
5/7 (71.43%)
$6.24 (-4.76%)
220
Sell
3
$2.89 (2627.27%)
3 years 3 months 29 days ago
3/3 (100%)
$2.54 (3.65%)
72
